Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Prof. MD. Yasemin Altuner Torun Liv Hospital Bahçeşehir Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time
Bladder Cancer Risk Factors: 7 Main Factors You Should Know
Bladder Cancer Risk Factors: 7 Main Factors You Should Know 4

Bladder cancer is a big health problem worldwide. In 2020, there were about 573,000 new cases and 213,000 deaths. We want to help you understand this disease better. Knowing the risks of bladder cancer is key to making good health choices.

Bladder cancer usually starts in the bladder’s lining. It grows and can spread to deeper layers. If not caught early, it can move to other parts like lymph nodes, bones, lungs, or liver. We’ll look at the main risk factors for bladder cancer bladder cancer risk factors.

Key Takeaways

  • Bladder cancer is a big health issue with hundreds of thousands of new cases every year.
  • Understanding risk factors is important for prevention and early detection.
  • Several factors can increase the risk of bladder cancer.
  • Early detection is key to effective treatment.
  • Knowing the risks helps in making informed health decisions.

The Global Impact of Bladder Cancer

Bladder Cancer Risk Factors: 7 Main Factors You Should Know
Bladder Cancer Risk Factors: 7 Main Factors You Should Know 5

Bladder cancer is a big health threat worldwide. It’s one of the most common cancers, leading to a lot of new cases every year. This makes it a major concern for public health.

In the United States, bladder cancer hits men more than women. It also affects White people more than Black people. The risk goes up with age, so older adults need to know the risks.

Current Statistics and Prevalence

Bladder cancer is widespread, with different rates in different places. It’s among the top ten cancers globally, based on bladder cancer statistics.

RegionIncidence RateMortality Rate
North America21.9 per 100,0004.3 per 100,000
Europe19.1 per 100,0004.1 per 100,000
Asia6.3 per 100,0002.5 per 100,000

The table shows bladder cancer rates vary by region. These numbers stress the need for risk factor awareness. Knowing the risks helps people protect their health.

The Importance of Risk Factor Awareness

Knowing the risks of bladder cancer is key to preventing and catching it early. The biggest risks are smoking and exposure to harmful chemicals at work. Knowing these can help people avoid these dangers.

By understanding bladder cancer’s global impact and its risks, we can fight it. Healthcare workers should teach patients about bladder cancer prevalence and how to lower their risk.

Understanding Bladder Cancer Risk Factors

Bladder Cancer Risk Factors: 7 Main Factors You Should Know
Bladder Cancer Risk Factors: 7 Main Factors You Should Know 6

Bladder cancer can be caused by several risk factors. Some of these can be controlled. Knowing these factors helps us make better health choices and lower our risk of bladder cancer.

Modifiable vs. Non-Modifiable Risk Factors

There are two main types of risk factors for bladder cancer. Modifiable risk factors are things we can change, like quitting smoking. Non-modifiable risk factors are things we can’t change, like our age or family history.

Even though we can’t change non-modifiable factors, knowing them helps us focus on modifiable ones. For example, smoking is a big risk factor for bladder cancer, causing about half of all cases.

  • Modifiable risk factors include:
  • Smoking
  • Exposure to certain chemicals at work
  • Chronic bladder irritation
  • Non-modifiable risk factors include:
  • Age
  • Genetic predisposition
  • Family history of bladder cancer

How Risk Factors Contribute to Cancer Development

Risk factors damage cell DNA, causing cells to grow out of control and form tumors. For bladder cancer, harmful substances from smoking or work can damage the bladder lining. This can lead to cancer.

Smoking is not just a bladder cancer risk. It’s also linked to other cancers because it introduces many carcinogens into the body. Exposure to certain chemicals at work also increases bladder cancer risk, showing why workplace safety is key.

Understanding how risk factors lead to bladder cancer helps us avoid harmful substances. This way, we can lower our risk of getting the disease.

Smoking: The Primary Risk Factor for Bladder Cancer

Smoking is the main cause of bladder cancer. It greatly increases the chance of getting this disease. We will look at how tobacco harms the bladder, compare smoker and non-smoker risks, and talk about quitting’s benefits for bladder health.

How Tobacco Carcinogens Affect the Bladder

Tobacco has many harmful chemicals called carcinogens. When you smoke, these chemicals get into your blood. They then go to your kidneys and end up in your urine. This exposes your bladder to these harmful substances, raising your cancer risk.

The chemicals in tobacco smoke can harm the bladder’s lining. This can lead to genetic changes in cells and possibly cancer. That’s why smokers are more likely to get bladder cancer than non-smokers.

Quantifying the Risk: Statistics for Smokers vs. Non-Smokers

Smokers face at least three times the risk of bladder cancer compared to non-smokers. The risk grows with how long and how much you smoke. For example, heavy smokers face a much higher risk than light smokers.

Smoking causes a big part of bladder cancer cases. Quitting can lower this risk over time. It might take a few years for the risk to be as low as a non-smoker’s.

Benefits of Smoking Cessation for Bladder Health

Stopping smoking is key to lowering bladder cancer risk. When you quit, your body starts to heal. The risk of bladder cancer goes down. Quitting is worth it for bladder health and overall health.

Key benefits of quitting smoking include:

  • Reduced risk of bladder cancer
  • Improved overall health
  • Lower risk of other smoking-related diseases
  • Increased life expectancy

Quitting smoking is tough, but doable with the right help. We urge smokers to get support to beat their addiction and better their health.

Occupational Chemical Exposure: The Second Major Risk Factor

There’s a strong link between work-related chemical exposure and bladder cancer. Many jobs expose workers to harmful chemicals. These chemicals can raise the risk of bladder cancer.

High-Risk Industries and Professions

Some jobs are more dangerous than others when it comes to bladder cancer. These include:

  • Painters and workers in the paint manufacturing industry
  • Firefighters exposed to combustion products
  • Hairdressers and barbers exposed to hair dyes
  • Workers in the rubber and textile industries
  • Those employed in dye manufacturing and printing industries

Workers in these fields often face chemicals like aromatic amines, benzidine, and beta-naphthylamine. These are known to cause cancer.

Specific Carcinogenic Chemicals in the Workplace

Some chemicals at work are linked to bladder cancer. These include:

  1. Aromatic amines used in dye manufacturing
  2. Benzidine and beta-naphthylamine used in various industrial processes
  3. Polycyclic aromatic hydrocarbons (PAHs) found in combustion products

These chemicals can get into the body through the skin or lungs. This can lead to bladder cancer.

Protective Measures and Regulations

To lower the risk of bladder cancer at work, there are steps and rules:

  • Use of personal protective equipment (PPE) such as gloves and masks
  • Implementation of engineering controls to minimize exposure
  • Regular monitoring of workplace air quality
  • Training programs for workers on handling hazardous chemicals

Groups like OSHA in the U.S. set safety standards. This includes limits on harmful chemicals.

By knowing the risks and taking action, we can lower bladder cancer rates in high-risk jobs.

Environmental Contaminants: Arsenic in Drinking Water

Drinking water with arsenic is linked to bladder cancer. Arsenic is found naturally in the earth and is a big health worry. It’s in our drinking water, posing a risk to many.

Mechanisms of Arsenic-Induced Bladder Damage

Arsenic can harm the bladder in several ways. It causes oxidative stress, damages DNA, and messes with cell functions. This leads to cancer in bladder cells.

Geographic Areas with Elevated Risk

Some places have more arsenic in their water. Mining and industrial sites, or natural deposits, increase this risk. Well water users are at higher risk because untreated wells have more arsenic than treated water.

Testing and Mitigation Strategies

Testing for arsenic is key to lowering risks. Homeowners, like those with wells, should check their water. Using certified filters, alternative systems, or bottled water can help. Public health efforts are also vital in keeping water safe.

Knowing the risks and acting early can protect our bladder health. It’s a big step in fighting bladder cancer and keeping us healthy.

Chronic Bladder Irritation and Inflammation

We know that chronic bladder irritation and inflammation raise the risk of bladder cancer. These issues come from long-term catheter use, frequent urinary tract infections, and bladder stones.

Long-term Catheter Use and Cancer Risk

Using a catheter for a long time increases the risk of bladder cancer. The catheter can irritate and inflame the bladder, making it more likely for cancer to develop. Research shows that people with long-term catheters face a higher risk of bladder cancer than others.

Healthcare providers should keep a close eye on patients with long-term catheters. They should also find ways to lower the risk of bladder irritation.

Recurrent Urinary Tract Infections

Recurrent urinary tract infections (UTIs) also raise the risk of bladder cancer. UTIs cause bladder inflammation, and repeated infections can damage the bladder lining. This damage can lead to cancerous changes over time.

Preventing UTIs through good hygiene and quick treatment can help lower bladder cancer risk.

Bladder Stones and Chronic Inflammation

Bladder stones can also cause chronic irritation and inflammation. These stones can irritate the bladder and lead to more infections, both of which increase cancer risk. Bladder stones often point to underlying issues that need to be fixed to avoid long-term problems.

Treating bladder stones and managing underlying conditions are key to reducing bladder cancer risk.

Understanding the risks of chronic bladder irritation and inflammation helps us take steps to lower bladder cancer risk. This can help prevent more cases of bladder cancer.

Parasitic Infections: Schistosomiasis

Schistosomiasis is linked to a higher risk of bladder cancer, mainly in areas where it’s common. This disease, caused by Schistosoma haematobium, is a big health problem in Africa and the Middle East.

The Connection Between Schistosomiasis and Bladder Cancer

Schistosomiasis causes long-term inflammation in the bladder, which may lead to cancer. The parasite’s eggs in the bladder wall can cause genetic changes and cancer. Research shows people with schistosomiasis are more likely to get bladder cancer than others.

The World Health Organization says schistosomiasis is a major health issue worldwide. It affects health and economies in many places. The link between schistosomiasis and bladder cancer shows we need better prevention and treatment in these areas.

Endemic Regions and Prevention Strategies

Schistosomiasis is common where sanitation is poor and clean water is scarce. In these places, prevention focuses on better sanitation, clean water, and treating infected people.

  • Improving sanitation and hygiene practices
  • Providing access to clean water
  • Implementing mass drug administration programs
  • Conducting public health education campaigns

Understanding the link between schistosomiasis and bladder cancer helps us target prevention better. We need a mix of public health actions and raising awareness to fight schistosomiasis and lower bladder cancer risk.

Previous Radiation Therapy and Medical Treatments

We know that past radiation therapy, like in the pelvis, raises the risk of bladder cancer. This is a worry for those who had radiation for other cancers in the pelvic area.

Pelvic Radiation and Secondary Cancer Risk

Radiation therapy is often used to treat cancers like cervical, prostate, and rectal cancer. But, radiation can harm the DNA of bladder cells, which might lead to cancer. The chance of getting bladder cancer after radiation depends on the treatment’s dose and length.

Research shows that people who got pelvic radiation therapy face a higher risk of bladder cancer. This risk is even higher if they were treated when they were younger. So, it’s key for these folks to know their risk and talk about monitoring with their doctor.

Monitoring Protocols for High-Risk Patients

For those who had pelvic radiation, regular checks are vital for catching bladder cancer early. Monitoring might include regular visits, urine tests, and imaging. The how often and what kind of monitoring depends on the person’s risk factors and health history.

Doctors might suggest more frequent checks for those at higher risk, like smokers or those with other bladder cancer risk factors. Early detection through regular checks can greatly improve treatment results. It’s important for patients to work with their healthcare team to create a monitoring plan that fits them.

By knowing the risks from past radiation and following monitoring advice, high-risk patients can take steps towards early detection and managing bladder cancer well.

Age and Genetic Factors in Bladder Cancer Risk

Two big things that affect bladder cancer risk are age and genetics. Knowing about these helps us fight bladder cancer better.

Increasing Risk with Age

As we get older, the chance of getting bladder cancer goes up. Most people find out they have it after 55. This is because our bodies get more damage over time and can’t fix it as well.

Things that make getting bladder cancer more likely with age include:

  • Long-term exposure to harmful substances
  • More genetic changes
  • Our DNA repair skills get weaker

Hereditary and Genetic Predisposition

Genetics also play a big part in bladder cancer risk. If your family has bladder cancer, you might be at higher risk. Some genetic changes, like in the TP53 gene, can also raise your risk.

The main genetic factors are:

  1. Having a family history of bladder cancer
  2. Carrying certain genetic mutations (like TP53 or RB1)
  3. Being part of a genetic syndrome that raises cancer risk

Knowing about these genetic and age-related risks helps us create better screening and prevention plans for those at higher risk.

Conclusion: Reducing Your Risk and Early Detection

Knowing the risk factors for bladder cancer helps us make better choices. We can lower our risk by quitting smoking and avoiding harmful chemicals at work. Also, being mindful of environmental pollutants is key.

Spotting bladder cancer early is vital for effective treatment. To do this, we should quit smoking, stay away from harmful work environments, and drink plenty of water. These steps can greatly reduce the chance of getting bladder cancer.

We stress the need for early detection and urge people to know their risk factors. This way, we can all live healthier lives and improve the quality of life for those with bladder cancer. Reducing bladder cancer risk needs a team effort from everyone involved.

FAQ

What are the main risk factors for bladder cancer?

Main risk factors include smoking, exposure to chemicals at work, and arsenic in water. Also, chronic bladder irritation, infections like schistosomiasis, and previous radiation therapy are risks. Age and genetics also play a part.

How does smoking contribute to the risk of bladder cancer?

Smoking is a big risk for bladder cancer. Carcinogens from tobacco get into the blood, then the kidneys filter them. These toxins damage the bladder lining, raising cancer risk.

What industries or professions are at high risk for occupational chemical exposure that can lead to bladder cancer?

Workers in manufacturing, dye, rubber, and paint face high risks. They are exposed to harmful chemicals like aromatic amines and polycyclic aromatic hydrocarbons.

How does arsenic in drinking water cause bladder cancer?

Arsenic in water damages the bladder by causing oxidative stress and DNA damage. It disrupts cell processes, leading to cancer.

What is the connection between schistosomiasis and bladder cancer?

Schistosomiasis increases bladder cancer risk. Chronic infection causes inflammation and irritation, leading to cancerous changes.

How does age influence the risk of bladder cancer?

Age raises bladder cancer risk, with most cases in people over 65. This is due to genetic damage and decreased cell repair ability with age.

Can genetic factors play a role in the risk of developing bladder cancer?

Yes, genetics can affect bladder cancer risk. Certain mutations can hinder detoxification and DNA repair, increasing cancer risk.

What are the benefits of smoking cessation for bladder health?

Quitting smoking greatly lowers bladder cancer risk. It prevents further bladder damage and reduces cancer risk.

How can individuals reduce their risk of bladder cancer?

To lower risk, quit smoking, avoid harmful chemicals, and test for arsenic in water. Manage bladder conditions and be aware of genetic predisposition.

What are the symptoms of bladder cancer that individuals should be aware of?

Look out for blood in urine, frequent or painful urination, and abdominal pain. If you notice these, see a doctor for evaluation.


References

National Center for Biotechnology Information. (2025). 7 Main Bladder Cancer Risk Factors You Should. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC10187602/

i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Get a Free Quote

Response within 2 hours during business hours

Clinics/branches
GDPR

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Prof. MD. Yasemin Altuner Torun Liv Hospital Bahçeşehir Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
Trusted Worldwide
30
Years of
Experience
30 Years Badge
Health Türkiye Accreditation

Trusted Worldwide

30 Years of Experience

Patient Reviews
Reviews from 9,651
4,9
Was this content helpful?
Your feedback helps us improve.
What did you like?
Share more details about your experience.
You must give consent to continue.

Thank you!

Your feedback has been submitted successfully. Your input is valuable in helping us improve.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology

Prof. MD. Yasemin Altuner Torun

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 174 42 01